Multi-Color Corp., a label design and printing services provider owned by Clayton Dubilier & Rice, filed for prepackaged bankruptcy after enough creditors agreed to back a plan to slash the company’s ...

Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at least $2.5 billion of debt for Covetrus, a technology company for veterinary ...

Clayton Dubilier & Rice is seeking $26 billion for its latest flagship private equity fund, an ambitious target that would count among the industry’s largest-ever fundraises. CD&R has begun ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition deal comes after ...

Multi-Color Corp.’s earnings were hit hard by lower customer demand in the third quarter as the label making firm’s debt obligations grow more daunting, according to people familiar with the situation ...

Once written off as relics of the early digital age, CD players are quietly making a comeback—and not just for nostalgic audiophiles. As streaming services compress sound for convenience, many music ...

These days, it has become very easy to watch your favorite movies and listen to top songs anytime, anywhere you want. There are music streaming platforms like Spotify where you can listen to your ...

NEW YORK, April 8, 2025 /PRNewswire/ -- CD&R (or the "Firm") announced today the appointment of Michael Harrington as Risk Director, a newly created position that will provide strategic risk ...

CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...

Resideo Technologies (REZI) has disclosed a new risk, in the Share Price & Shareholder Rights category. The CD&R Stockholder, holding approximately 11% of Resideo Technologies’ total voting power as ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S.